WPRIM Management System> DCMS> Chinese Journal of Urology> 2020> 41> 5

Volume: 41 Issue: 5

1. Proposal and thinking of renaming type Ⅲ prostatitis to prostate-pelvic syndrome Page:326—329
2. Research development of postoperative intravesical chemotherapy for upper tract urothelial carcinoma Page:397—400
3. A multicenter clinical study of comparing the efficacy of two mid-urethral slings in the treatment of female stress urinary incontinence Page:368—373
4. A comparative study of sexual function preservation after robot-assisted and laparoscopic radical cystectomy and orthotopic bladder reconstruction Page:356—361
5. Research development of the therapy in patients with locally advanced upper tract urothelial carcinoma Page:389—393
6. The application of adjuvant radiotherapy after radical nephroureterectomy in the treatment of upper tract urothelial carcinoma Page:394—396
7. A case report of renal fibrosclerotic nodule with calcification Page:385—386
8. A case report of transperineal ultrasound-guided transperineal prostate biopsy to diagnose an abdominoperineal resection patient Page:387—388
9. Prognostic relevance of preoperative platelet-to-albumin ratio(PAR) in patients with upper urinary tract urothelial carcinoma Page:341—347
10. Upper tract urothelial carcinoma: small field, outstanding achievements Page:321—325
11. A missed diagnosis case with squamous cell carcinoma of renal pelvis Page:382—384
12. Clinical analysis of squamous cell carcinoma of renal pelvis Page:348—351
13. The diagnosis and treatment of primary adenocarcinoma of the upper urinary tract Page:352—355
14. Construction of primary prostate cancer cell bank using conditional reprogramming cell technology Page:374—381
15. The update interpretation of 2020 EAU prostate cancer guideline(Part Ⅱ) Page:332—333
16. The update interpretation of 2020 EAU prostate cancer guideline(Part Ⅰ) Page:330—331
17. Impact of tumor architecture on prognosis of patients with upper tract urothelial carcinoma Page:334—340
18. 125I low-dose-rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer Page:362—367